The ability of staphylococcal strains isolated from different anatomical sites in 133 healthy goats to produce toxic shock syndrome toxin 1 (TSST-1) and the presence of antibodies to this toxin in serum and milk were studied. The enzyme-linked immunosorbent assay method was used to detect both the toxin and the presence of antibodies. Of a total of 342 staphylococcal strains studied, 86 (25.2%) were found to produce TSST-1. Specific antibodies to TSST-1 were found in the serum of 57 (42.9%) of the animals studied and the milk of 63 (47.4%) of the animals. These results suggest that goats are frequently in contact with staphylococci that produce TSST-1, a toxin usually associated with Staphylococcus aureus strains isolated from cases of toxic shock syndrome in humans.
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Toxic shock syndrome (TSS), a systemic illness caused by Staphylococcus aureus, was first described by Todd et al. (29) and is presumed to be produced mainly by a staphylococcal protein originally labeled enterotoxin F (2) and pyrogenic exotoxin C (26) and later called toxic shock syndrome toxin 1 (TSST-1) (3) . This protein is synthesized by almost all menstrual (2, 4) and many nonmenstrual (13, 26) strains of S. aureus isolated from patients with the clinical manifestations of TSS, although it is likely that staphylococcal enterotoxins other than TSST-1 play an important role in the disease (6, 13, 25) . The protein is also synthesized by S. aureus strains from healthy subjects (15, 20, 24, 27) . The fact that no anti-TSST-1 antibodies were found in TSS patients (1), whereas healthy subjects had a high percentage of antibodies (15, 20, 24, 27, 32) , seems to indicate that subjects with no antibodies to TSST-1 are more prone to the syndrome than those with antibodies (20) .
There are few reports concerning the toxinogenic capacity of staphylococci isolated from animals. TSST-1-producing S. aureus has been isolated from poultry (10), goat udder dermatitis and nasal mucosa (19) , and mastitic milk of cows (16) and goats (7) . In this study, the ability of staphylococci isolated from different body sites in healthy goats to produce TSST-1 was examined, and the presence of antibodies against the toxin in the serum and milk of these animals was determined.
A total of 133 healthy female goats were examined. Sterile swabs were rubbed on the nasal mucosa and the skin of the axilla, udder, and nipple. Milk (25 ml from each compartment) was collected aseptically in sterile containers.
Blood-collecting needles and silicone-coated tubes (Venoject; Terumo Co., Leuven, Belgium) were used for blood sampling. Sera (31) . In brief, coagulase-positive strains were identified according to the criteria proposed by Devriese and H'jek (8) , and coagulase-negative strains were identified according to the criteria suggested by Devriese et al. (9) .
A 500-,ul sample of the 18-h broth inoculated with the staphylococcal strains was poured onto the surface of cellophane membranes (Spectrapor membrane tubing; Spectrum Medical Industries Inc., Los Angeles, Calif.) containing brain heart infusion agar, as described by Hallander (14) , and harvested after 24 h with 3.0 ml of 0.01 M Na2HPO4.
TSST-1 present in extracts was detected by the enzymelinked immunosorbent assay (ELISA) method described by Freed et al. (12) , with a detection limit of 0.625 ng of TSST-1 per ml. TSST-1 was purified according to the procedure described by Parsonnet et al. (22) , and antibodies were raised in New Zealand White rabbits by inoculating them with the purified protein according to the method proposed by Parsonnet et (Table 1) . There are few reports on TSST-1 production by S. aureus isolated from animals (7, 10, 16, 19) , probably because this toxin has usually been associated with human S. aureus. In studies with goats, TSST-1-producing S. aureus has always been isolated from pathological conditions such as dermatitis (24) or mastitic milk (7), while Jones and Wieneke (16) reported the isolation of toxinogenic strains in pure culture from severe cases of bovine mastitis. In all these studies, the authors found a high percentage of animals harboring TSST-1-producing staphylococci, usually in association with staphylococcal enterotoxin C. Many (79%) of the TSST-1-producing strains isolated by us also produced enterotoxin C (30) . We have isolated TSST-1-producing strains from all the sites studied except the axillar fold (Table 1) . However, the highest percentage came from the mammary area and from milk, which were the sources of 90.7% of the total isolates.
In addition, in most reports S. aureus is the strain usually associated with the production of TSST-1, while in this study 16 .5% of the coagulase-negative strains were determined to be TSST-1 producers ( Table 1) . The ability to synthesize TSST-1 has been described for human coagulase-negative strains identified as Staphylococcus epidermidis (2, 5, 17) , although some authors do not agree with these results (18, 21) . Many of the strains belonging to certain coagulasenegative species isolated in the present study proved to be toxinogenic as determined by the technique that we used ( Table 2) . Although the technique used for coagulase analysis made use of a conventional coagulase test tube (8), it was not the only method used for identifying coagulase-negative species (31); their characterization was the result of thorough analysis by a variety of methods which followed the criteria proposed by Devriese et al. (9) .
Specific antibodies were found in the serum of 57 (42.9%) and in the milk of 63 (47.4%) of the 133 animals studied. Of 57 animals from which TSST-1-producing staphylococci were isolated, antibodies were found in the serum of 25 (43.9%) and in the milk of 32 (56.0%). Of 76 animals from which no TSST-1-producing staphylococci were isolated, antibodies to TSST-1 were found in the serum of 32 (42.1%) and in the milk of 31 (40.8%). Thus, there was no significant difference between the percentage of antibodies detected in carriers and the percentage of antibodies detected in noncarriers of toxin-producing staphylococcal strains. Several reports have shown that a high percentage of healthy humans have specific anti-TSST-1 antibodies associated with the isolation of toxin-producing S. aureus from the nasal mucosa (15, 20, 24) . Notermans et al. (20) suggest that individuals lacking specific anti-TSST-1 antibodies may be more susceptible to TSS than those with antibodies. So far, the presence of anti-TSST-1 antibodies in animals has not been studied, paralleling the low number of studies of TSST-1 production by staphylococcal isolates from nonhuman species. However, in the goats sampled in this experiment, a high percentage of TSST-1-producing staphylococci was isolated (Tables 1 and 2 ) and a high number of animals having specific antibodies detected both in serum and in milk were identified. In a study using commercial cow's milk, Thompson et al. (28) detected a high incidence of antibodies against TSST-1, sometimes at high titers.
The results regarding the isolation of TSST-1-producing staphylococci and the presence of specific antibodies in the milk and serum of the healthy goats studied suggest that these animals may be frequently exposed to TSST-1-producing strains, either habitually or through infection. It was concluded that a study of the role of this toxin in infectious processes in animals and of the role that these animals, as frequent carriers of this type of staphylococci, may have in human health would be of great value. We are grateful for the technical assistance of E. Fernandez
Corrales.
